Back

Nationwide implementation of PCSK9--targeted therapies after myocardial infarction and ischemic stroke: structural barriers and disparities in a universal healthcare system

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Implementing novel lipid‑lowering therapies Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Petra Sedova

University Hospital Brno, Brno (Czechia)

5 More presentations in this session

Presentation thumbnail
The nocebo effect in statin therapy: clinical implications for adherence and cardiovascular outcomes
Doctor M. Sargsyan (Yerevan, AM)
Abstract
Presentation thumbnail
Impact of evolocumab on coronary plaque stratified by very high-risk ASCVD status: a YELLOW III sub study
Doctor P. C Revaiah (New York, US)
Abstract
Presentation thumbnail
Comparative effectiveness of lipid-lowering regimens for achieving ESC LDL-cholesterol targets in acute coronary syndrome: a real-world cohort analysis
Doctor A. Romiou (Marousi, GR)
Abstract
Presentation thumbnail
Variability in lipoprotein(a) measurements in ODYSSEY OUTCOMES: is one-and-done testing sufficient?
Professor P. Steg (Paris, FR)
Abstract
Presentation thumbnail
Atorvastatin for prevention of chemotherapy-induced cardiotoxicity: a 5-year propensity-matched cohort study of 800 patients
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract

Access the full session

Session thumbnail
Implementing novel lipid‑lowering therapies

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study
1 September 2025
thumbnail
Congress Presentation
Guideline-directed low-density lipoprotein cholesterol management following acute ischemic stroke: findings from Clalit health services
28 August 2023
thumbnail
Congress Presentation
Gender disparities in management and treatment in acute myocardial infarction - a german nationwide real-life analysis
1 September 2020
thumbnail
Congress Presentation
Secondary prevention of coronary artery disease: a retrospective observational analysis of italian healthcare administrative data
7 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources